Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

Juan Decara(Instituto de Investigación Biomédica de Málaga), Juan Suárez(Ministerio de Ciencia, Innovación y Universidades)

Frontiers in Pharmacology

May 27, 2020

10.3389/fphar.2020.00730

Cited by 192

Related Papers

Pharmacological Administration of the Isoflavone Daidzein Enhances Cell Proliferation and Reduces High Fat Diet-Induced Apoptosis and Gliosis in the Rat Hippocampus

|PLoS ONE|2013|65

Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity

|Nutrients|2021|24

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

|Disease Models & Mechanisms|2015|22

Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol

|Nutrients|2021|21

Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity

|Nutrients|2023|18